You just read:

U.S. FDA Announces Joint Advisory Committee Review of Mallinckrodt's Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)

News provided by

Mallinckrodt plc

Oct 08, 2018, 06:45 ET